Structure-guided stabilization of the SARS-CoV-2 spike protein for vaccines and diagnostics. | Pandemic PACT Tracker

Key facts

Disease
COVID-19
start year
2020
Known Financial Commitments (USD)
$100,000
Funder
Gates Foundation
Principal Investigator
N/A
Research Location
United States of America
Lead Research Institution
University of Texas at Austin
Research Priority Alignment
N/A

Research Category
Therapeutics research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable

Abstract

N/A

Publicationslinked via Europe PMC

Last Updated:42 minutes ago

View all publications at Europe PMC

Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses.

Rapid characterization of spike variants via mammalian cell surface display.

Expression and characterization of SARS-CoV-2 spike proteins.